Insulin analogues: Searching for a physiological replacement Análoges de insulina: En búsqueda del reemplazo fisiológico
Author
dc.contributor.author
Eyzaguirre C., Francisca
Author
dc.contributor.author
Codner Dujovne, Ethel
Admission date
dc.date.accessioned
2019-03-11T12:51:01Z
Available date
dc.date.available
2019-03-11T12:51:01Z
Publication date
dc.date.issued
2006
Cita de ítem
dc.identifier.citation
Revista Medica de Chile, Volumen 134, Issue 2, 2018, Pages 239-250
Identifier
dc.identifier.issn
00349887
Identifier
dc.identifier.issn
07176163
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164132
Abstract
dc.description.abstract
Insulin analogues, developed by molecular engineering, have structural changes in the A and B insulin chains. These modifications change their action profile, rendering insulin replacement closer to physiology. Rapid acting analogues like lispro, a spart and glulisine, are absorbed rapidly from the subcutaneous tissue to the circulation. In addition, two long acting insulin analogues have been developed: glargine and detemir. The combination of a long acting insulin, to maintain baseline levels, and multiple daily doses of a rapid acting analogue are the mainstay of basal-bolus therapy. Multiples studies have compared human insulin (NPH and regular) with insulin analogues in patients with type 1 or 2 diabetes mellitus, showing an improvement in the metabolic control, fewer hypoglycemic events and better quality of life. In summary, insulin analogues offer new therapeutic options and allow an individualized intensive treatment.
Carrasco, Albert; Recabarren, Mónica P.; Rojas García, Pedro P.; Gutiérrez, Mario; Morales, Karina; Sir Petermann, Teresa; Recabarren, Sergio E.(Nature, 2020)
Hyperandrogenemia and metabolic disturbances during postnatal life are strongly linked both to polycystic ovary syndrome and other conditions that arise from prenatal exposure to androgen excess. In an animal model of this ...
Context: Skeletal muscle insulin resistance is proposed to result from impaired skeletal muscle lipid oxidative capacity. However, there is no evidence indicating that muscle lipid oxidative capacity is impaired in healthy ...
Villavicencio,; Iñíguez Vila, Germán; Johnson,; Gabler Neale, Fernando; Palomino,; Vega Vega, Luis Felipe(Journals of Reproduction and Fertility Ltd, 2002)
The aim of the present study was to investigate the action of insulin-like growth factor I (IGF-I) and insulin-like growth factor-binding protein 3 (IGFBP-3) on steroidogenesis and apoptosis in human corpus luteum during ...